Tissue banking in a regional hospital: A promising future concept? first report on fresh frozen tissue banking in a hospital without an integrated institute of pathology

World Journal of Surgery

Volumn 36, Issue 10, 2012, Pages 2300-2304

  Von Strauss Und Torney, Marco ^a,b   Güller, Ulrich ^c   Rezaeian, Farid ^a,d   Brosi, Philippe ^a   Terracciano, Luigi ^e   Zuber, Markus ^a  

^a KANTONSSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; FEASIBILITY STUDY; FEMALE; FORECASTING; FREEZING; HEALTH CARE FACILITY; HOSPITAL; HUMAN; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PILOT STUDY; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; FEMALE; FORECASTING; FREEZING; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PATHOLOGY; PILOT PROJECTS; PROSPECTIVE STUDIES; TISSUE BANKS;

EID: 84867758773     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1656-3     Document Type: Article

References (24)

1. Sauter G, Simon R (2002) Predictive molecular pathology. N Engl J Med 347:1995-1996
2. Cardoso F, Piccart-Gebhart M, Van't Veer L et al (2007) The MINDACT trial: The first prospective clinical validation of a genomic tool. Mol Oncol 1:246-251
3. Mook S, Schmidt MK, Weigelt B et al (2010) The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age. Ann Oncol 21:717-722
4. Nuyten DS, Hastie T, Chi JT et al (2008) Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification. Eur J Cancer 44:2319-2329
5. Nuyten DS, Kreike B, Hart AA et al (2006) Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 8:R62
6. Van de Vijver MJ, He YD, van't Veer LJ et al (2002) A geneexpression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009
7. Herpel E, Koleganova N, Schirmacher P (2008) Tissue bank of the National Centre for Tumour Disease: An innovative platform for translational tumour. Pathologe 29(Suppl 2):204-209
8. Knox K, Kerr DJ (2004) Establishing a national tissue bank for surgically harvested cancer tissue. Br J Surg 91:134-136
9. LiVolsi VA, Clausen KP, Grizzle W et al (1993) The cooperative human tissue network: An update. Cancer 71:1391-1394
10. Riegman PH, Dinjens WN, Oomen MH et al (2006) TuBaFrost 1: Uniting local frozen tumour banks into a European network: An overview. Eur J Cancer 42:2678-2683
11. Stege A, Hummel M (2008) Experience with establishment and operation of a biobank. Pathologe 29(Suppl 2):214-217
12. Sobin LH, Wittekind C (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York
13. Credit Suisse AG (2010) Durchschnittsdevisenkurse 2009. https:// www.credit-suisse.com/ch/unternehmen/kmugrossunternehmen/ doc/ devisendurchschnittskurse-2009-de.pdf/. Accessed 22 June 2011
14. Chu TY, Hwang KS, Yu MH et al (2002) A research-based tumor tissue bank of gynecologic oncology: Characteristics of nucleic acids extracted from normal and tumor tissues from different sites. Int J Gynecol Cancer 12:171-176
15. Leyland-Jones BR, Ambrosone CB, Bartlett J et al (2008) Recommendations for collection and handling of specimens from group breast cancer clinical trials. J Clin Oncol 26:5638-5644
16. Mager SR, Oomen MH, Morente MM et al (2007) Standard operating procedure for the collection of fresh frozen tissue samples. Eur J Cancer 43:828-834
17. Guller U (2006) Surgical outcomes research based on administrative data: Inferior or complementary to prospective randomized clinical trials? World J Surg 30:255-266. doi: 10.1007/s00268-005-0156-0
18. Guller U (2008) Caveats in the interpretation of the surgical literature. Br J Surg 95:541-546
19. Imamura K, McKinnon M, Middleton R et al (1997) Reliability of a comorbidity measure: The index of co-existent disease (ICED). J Clin Epidemiol 50:1011-1016
20. Janson M, Edlund G, Kressner U et al (2009) Analysis of patient selection and external validity in the Swedish contribution to the COLOR trial. Surg Endosc 23:1764-1769
21. Gunderson LL, Jessup JM, Sargent DJ et al (2010) Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 28:264-271
22. O'Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96:1420-1425
23. TARMED Suisse (2010). TARMED Version 1.07.00. http:// www.tarmedsuisse.ch/86.html/. Accessed 3 Feb 2011
24. Garcia-Granero E, Faiz O, Flor-Lorente B et al (2011) Prognostic implications of circumferential location of distal rectal cancer. Colorectal Dis 13:650-657